Pro tip: Through its influence on LH, DSIP can be an interesting addition during PCT
GLP-1 RAs complement these effects by reducing systemic hyperinsulinemia a key promoter of CRC in T2DM lowering obesity-related inflammation, and exerting direct anti-proliferative effects on colonic epithelium [34, 35]
The practical implication is clear: if lowdose metformin begins its work in the brain, future therapies may achieve control with lower exposure or target similar neural circuits more precisely, a direction suggested by the Science Advances research
Both TRIUMPH-2 and TRIUMPH-3 met their primary endpoints, expanding the clinical evidence for retatrutide in two of obesitys most significant comorbidities: type 2 diabetes and established cardiovascular disease
A new national survey by the National Consumers League (NCL) found that widespread confusion already exists among women: more than 70% believe compounded GLP-1s are only on the market if they have been tested and proven safe, and more than half (53%) think compounded GLP-1s have received FDA approval